Sunway Healthcare signs underwriting agreement ahead of 2026 IPO

The agreement involves six banks.

Sunway Healthcare Holdings Berhad (SHH) has signed an underwriting agreement for its planned initial public offering (IPO) and listing on the Main Market of Bursa Malaysia Securities Berhad.

The agreement involves six banks, namely Maybank Investment Bank Berhad, AmInvestment Bank Berhad, Affin Hwang Investment Bank Berhad, CIMB Investment Bank Berhad, RHB Investment Bank Berhad, and Kenanga Investment Bank Berhad.

The IPO, expected in the first quarter of 2026, will offer up to 1.969 billion shares, including 1.394 billion existing shares and 575 million new shares.

Of these, 1.624 billion shares will be allocated to institutional investors (14.1% of the enlarged share capital) and 345 million to retail investors (3.0%).

Maybank Investment Bank and AmInvestment Bank will act as joint principal advisers, global coordinators, bookrunners, and underwriters for the IPO.

Dato’ Beng Long Lau, president of SHH, said the underwriting deal reflects strong confidence from the banks. “It is an endorsement of our purpose, our staff and doctors, and our long-term commitment to delivering quality, safe, and sustainable healthcare.”

Michael Oh-Lau, CEO of Maybank Investment Bank, called the IPO “a timely platform for growth,” whilst Christopher Ng, CEO of AmInvestment Bank, highlighted SHH’s focus on clinical quality, patient-centered care, and nationwide expansion.